Polomar Health Services, Inc. (PMHS)
OQB · Healthcare · Pharmaceutical Retailers
Closing price as of 2026-07-28 · Source: TEK2day Finance
Key Metrics
About Polomar Health Services, Inc.
Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 5K | 6K | 632K | 1.0M |
| Gross Profit | 4K | 4K | 449K | 550K |
| Operating Income | -563K | -629K | -8.9M | -7K |
| Net Income | -606K | -650K | -9.0M | -25K |
| Diluted EPS | $-0.02 | $-0.02 | $nan | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 35K | 42K | 59K | 648K |
| Gross Profit | 35K | 38K | 31K | 460K |
| Operating Income | -181K | -441K | -1.3M | -10.6M |
| Net Income | -181K | -588K | -1.3M | -10.7M |
| Diluted EPS | $-0.00 | $-0.02 | $-0.05 | $nan |